178993-28-7

Basic information

• Product Name: Benzenamine, 2-ethoxy-4-fluoro- (9CI)
• Synonyms: Benzenamine, 2-ethoxy-4-fluoro- (9CI)
• CAS NO: 178993-28-7
• Molecular Formula: C₈H₁₀FNO
• Molecular Weight: 155.1695032
• Product Categories: METHOXY;HALIDE
• Mol File: 178993-28-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 226.1±20.0 °C(Predicted)
• Appearance: /
• Density: 1.137±0.06 g/cm3(Predicted)
• PKA: 4.54±0.10(Predicted)
• CAS DataBase Reference: Benzenamine, 2-ethoxy-4-fluoro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-ethoxy-4-fluoro- (9CI)(178993-28-7)
• EPA Substance Registry System: Benzenamine, 2-ethoxy-4-fluoro- (9CI)(178993-28-7)

Safety Data

• Hazardous Substances Data: 178993-28-7(Hazardous Substances Data)

Upstream product

• 446-36-6 5-fluoro-2-nitrophenol 
• 28987-44-2 5-fluoro-2-nitrophenyl ethyl ether 

Relevant articles and documents

AMINO PYRIMIDINE COMPOUND FOR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY

An amino pyrimidine compound for inhibiting protein tyrosine kinase activity, a pharmaceutical composition thereof, preparation therefor, and an application thereof. Specifically, an amino pyrimidine compound represented by formula (I), R1, R2, L, Y, R6, W, A, m, and n being defined in the specification, and a pharmaceutically acceptable salt, a stereoisomer, a solvent compound, a hydrate, a polymorphism, a prodrug, or an isotope variant thereof. The compound can be used for treating and/or preventing protein tyrosine kinase-related diseases such as cell proliferative diseases, cancers, and immune diseases.

An arylamino pyrimidine compound and crystals of salts of the compound

The invention provides an arylamino pyrimidine compound and crystals of salts thereof, belongs to the technical fields of medicines and chemical engineering, and particularly relates to N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-ethyoxyl-5-(4-(1-methy

Pyrimidine or triazine derivative, and preparation method and use thereof

The invention relates to an arylaminopyrimidine or triazine derivative, and a preparation method, a medicinal composition and a use thereof, and concretely relates to a compound represented by formula I, or a pharmaceutically acceptable salt or a solvate thereof. In the formula I, R1 to R7, X and Y are defined in the description and claims. The invention also relates to a preparation method of the compound of formula I, the medicinal composition containing the compound, and the pharmacy use of the compound and the medicinal composition. The compound of formula I is an effective tyrosine kinase irreversible inhibitor, and especially has a strong inhibition effect on EGFR-T790M drug-resistant tumors.